DrJonathan Danon

“PROTAxanes” – A novel solution “around” undruggable disease proteins

A PROTAC-BASED DEGRADATION OF TDP-43 IN THE TREATMENT AGAINST NEURODEGENERATIVE DISORDERS

Advancing methamphetamine profiling capabilities in Australia

An anxiolytic target on the edge of the mitochondria: modulating neurosteroid biosynthesis via the 18 kDa translocator protein (TSPO)

Design and Development of New Ligands for Imaging P2Y12

Design and development of senolytic compounds for the treatment of neurodegenerative diseases.

Design and synthesis of TSPO ligands as novel anxiolytic therapeutics

Expanding the Scope of CNS Drug Discovery

Exploration of Novel Mechanically Interlocked Drug Molecules

Identification of Novel Modulators for Neurodegenerative Disease States

Machine Learning Driven Pharmacophore Generation

Molecules that modulate brain function

P2X7 Receptor Antagonists and Their Role in Inflammation

Small molecule modulation of neurotoxic TDP-43

Synthesis of Altenusin Analogues as Tau Aggregation Inhibitors

Targeting the Oxytocin and Vasopressin System for the Treatment of Neuropsychiatric Disorders.

Total synthesis of marine ladder toxins and a synthetic ribosome

VAST Fragment Based Drug Discovery towards Novel Purinergic Receptor Inhibitors